zepbound a glp 1 Eli Lilly's New $299 Month-Long GLP‑1 Injector Shows Why It's Winning the Weight‑Loss Race Eli Lilly stock soars on

A study published in JAMA in January 2025 which looked at more than 125,000 overweight or obese people found that nearly 47% of those with type 2 diabetes and 65% of those without diabetes stopped taking their prescribed GLP-1s within a year of starting them

[DOI] [PMC free article] [PubMed] [Google Scholar] 79.Franklyn JA

See the full article for detailed analysis

Food and Drug Administration on the drug in the fourth quarter of this year

At BioPeptics, Tirzepatide is supplied in sterile lyophilized vial form for enhanced stability and is independently third-party tested for identity and purity verification

The term usually refers to BPC-157 and TB-500 sold together, either as separate vials or as a co-formulated blend